Literature DB >> 14988309

New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: an endocrinologist's view.

Jaime A Davidson1, Alan Wilkinson.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14988309     DOI： 10.2337/diacare.27.3.805

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  33 in total

1.  Donation after cardiac death: a 29-year experience.

Authors:  Janet M Bellingham; Chandrasekar Santhanakrishnan; Nikole Neidlinger; Philip Wai; Jim Kim; Silke Niederhaus; Glen E Leverson; Luis A Fernandez; David P Foley; Joshua D Mezrich; Jon S Odorico; Robert B Love; Nilto De Oliveira; Hans W Sollinger; Anthony M D'Alessandro
Journal:  Surgery       Date:  2011-10       Impact factor: 3.982

2.  Can statins reduce the incidence of new-onset diabetes post transplantation?

Authors:  Boaz Hirshberg
Journal:  Curr Diab Rep       Date:  2005-08       Impact factor: 4.810

3.  [Sequelae of organ transplantation].

Authors:  S Ciesek; M Manns; C Strassburg
Journal:  Internist (Berl)       Date:  2006-03       Impact factor: 0.743

4.  Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation.

Authors:  Zahra Parvizi; Negar Azarpira; Leila Kohan; Masumeh Darai; Kourosh Kazemi; Mohamad Mehdi Parvizi
Journal:  Mol Biol Rep       Date:  2014-07-05       Impact factor: 2.316

Review 5.  Pharmacogenetics of posttransplant diabetes mellitus.

Authors:  P Lancia; T Adam de Beaumais; E Jacqz-Aigrain
Journal:  Pharmacogenomics J       Date:  2017-03-28       Impact factor: 3.550

6.  Variants of the adiponectin and adiponectin receptor-1 genes and posttransplantation diabetes mellitus in renal allograft recipients.

Authors:  Eun Seok Kang; Faidon Magkos; Beom Seok Kim; Rihong Zhai; Li Su; Yu Seun Kim; David C Christiani; Hyun Chul Lee; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2011-11-02       Impact factor: 5.958

7.  A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation.

Authors:  Michael Haidinger; Johannes Werzowa; Hans-Christian Voigt; Johannes Pleiner; Gunar Stemer; Manfred Hecking; Dominik Döller; Walter H Hörl; Thomas Weichhart; Marcus D Säemann
Journal:  Trials       Date:  2010-10-06       Impact factor: 2.279

8.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Authors:  Etie S Moghissi; Mary T Korytkowski; Monica DiNardo; Daniel Einhorn; Richard Hellman; Irl B Hirsch; Silvio E Inzucchi; Faramarz Ismail-Beigi; M Sue Kirkman; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2009-05-08       Impact factor: 19.112

9.  Post-transplant diabetes mellitus.

Authors:  Marília B Gomes; Roberta A Cobas
Journal:  Diabetol Metab Syndr       Date:  2009-10-05       Impact factor: 3.320

10.  Pancreatic islet transplantation.

Authors:  Maria Lúcia Corrêa-Giannella; Alexandre S Raposo do Amaral
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.